WV: Diversion of Drugs, 1 unitPage 10 of 10

8. References / Quiz Login or Register


Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline:
1-800-662-HELP (4357) or
1-800-487-4889 (TDD—for hearing impaired)

Behavioral Health Treatment Locator

(search by address, city, or zip code)

Buprenorphine Treatment Physician Locator


Centers for Disease Control and Prevention (CDC)



American Society of Addiction Medicine (ASAM). (2015). National Practice Guideline in the Use of Medications for the Treatment of Addiction Involving Opioid Use. Retrieved April 8,2018 from https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf.

American Society of Addiction Medicine (ASAM). (2012). Public policy statement on measures to counteract prescription drug diversion, misuse, and addiction. Retrieved April 20, 2018 from http://www.asam.org.

American Society of Addiction Medicine (ASAM). (2017). June 16, 2017 Letter to Chris Christie, Chair, President’s Commission on Combating Drug Addiction and the Opioid Crisis. Retrieved 4/20/18 from https://www.asam.org/docs/default-source/advocacy/letters-and-comments/asam-recommendations-6-16-17.pdf?sfvrsn=2#search=%22trends%20in%20pain%20management%22.

Butler SF, Budman SH, Fanciullo GJ, et al. (2007). Cross Validation of the Current Opioid Misuse Measure (COMM) to Monitor Chronic Pain Patients on Opioid Therapy. Retrieved July 5, 2018 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955853/.

Centers for Disease Control and Prevention (CDC). (2017a). Annual Surveillance Report of Drug-Related Risks and Outcomes—United States, 2017. Surveillance Special Report 1. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2017. Retrieved April 14, 2018 from https://www.cdc.gov/drugoverdose/pdf/pubs/2017-cdc-drug-surveillance-report.pdf.

Centers for Disease Control and Prevention (CDC). (2017b). Guideline for Prescribing Opioids for Chronic Pain. Fact Sheet. Retrieved 4/15/2018 from https://www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf.

Chabal C, Erjavec MK, Jacobson L, et al. (1997). Prescription Opiate Abuse in Chronic Pain Patients: Clinical Criteria, Incidence, and Predictors. Retrieved July 5 2018 from https://journals.lww.com/clinicalpain/Abstract/1997/06000/Prescription_Opiate_Abuse_in_Chronic_Pain.9.aspx.

Compton P, Darakjian J, Miotto K. (2008, October). Introduction of a Self-report Version of the Prescription Drug Use Questionnaire and Relationship to Medication Agreement Non-Compliance. J Pain Symptom Manage. 36(4): 383–95.

Controlled Substance Automated Prescription Program (CSAPP). (2018). West Virginia Board of Pharmacy. Retrieved April 8, 2018 from https://www.csappwv.com/Account/Login.aspx?ReturnUrl=%2f.

Corsini E, Zacharoff KL. (2014, 2011). Definitions related to aberrant drug-related behavior: Is there correct terminology? Retrieved 4/20/2018 from https://www.painedu.org/definitions-aberrant-drug-related-behavior/.

Council on Economic Advisers (CEA). (2017). The Underestimated Cost of the Opioid Crisis. Retrieved 4/15/2018 from https://www.whitehouse.gov/sites/whitehouse.gov/files/images/The%20Underestimated%20Cost%20of%20the%20Opioid%20Crisis.pdf.

Dixon DW. (2018). Opioid Abuse: Practice Essentials, Background, Pathophysiology Retrieved 4/15/2018 from https://emedicine.medscape.com/article/287790-overview#showall.

Dowling LS, Gatchel RJ, Adams LL. (2007). An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain. Retrieved July 5, 2018 from https://www.ncbi.nlm.nih.gov/pubmed/18181380.

Drug Enforcement Administration (DEA), Diversion and Control Division. (2018). Controlled substances. Retrieved July 5, 2018 from https://www.deadiversion.usdoj.gov/schedules/.

Food and Drug Administration (FDA). (2014). Opioid Patient-Prescriber Agreement. Retrieved 4/20/2018 from https://www.fda.gov/Drugs/DrugSafety/SafeUseInitiative/ucm188762.htm#opioidppa.

Florence CS, Zhou C, Luo, F, Xu L. (2016, October). The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Medical Care 10:901–906. Retrieved 4/14/2018 from https://journals.lww.com/lww-medicalcare/Abstract/2016/10000/The_Economic_Burden_of_Prescription_Opioid.2.aspx.

Hedegaard H, Warner M, Miniño AM. (2017). Drug Overdose Deaths in the United States 1999–2016. NCHS Data Brief, No. 294. Hyattsville, MD: National Center for Health Statistics. Retrieved 4/14/2018 from https://www.cdc.gov/nchs/products/databriefs/db294.htm.

Joint Commission, The. (2018). Facts about Joint Commission Accreditation Standards for Health Care Organizations: Pain Assessment and Management. Retrieved 4/7/2018 from https://www.jointcommission.org/facts_about_joint_commission_accreditation_standards_for_health_care_organizations_pain_assessment_and_management/.

Katz J. (2017, January 5). Drug Deaths in America Are Rising Faster than Ever. The New York Times. Retrieved 4/14/2018 from https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html.

National Center on Addiction and Substance Abuse (CASA). 2017. Who Develops Addiction? Retrieved 4/8/2018 from https://www.centeronaddiction.org/addiction/addiction-risk-factors.

National Council of State Boards of Nursing (NCSBN). (2011). Substance Use Disorder in Nursing: A Resource Manual and Guidelines for Alternative and Disciplinary Monitoring Programs. Retrieved April 18, 2018 from https://www.ncsbn.org/SUDN_11.pdf. [Still a valid source. No update made yet.]

National Council of State Boards of Nursing (NCSBN). (2014). What You Need to Know About Substance Use Disorder in Nursing. Retrieved April 7, 2018 from https://www.ncsbn.org/SUD_Brochure_2014.pdf.

National Institute on Drug Abuse (NIDA). (2018). Misuse of Prescription Drugs. Retrieved 4/20/18 from https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/2609-misuse-of-prescription-drugs.pdf.

National Institute on Drug Abuse (NIDA). (2018). Opioid Summaries by State: West Virginia. Retrieved April 14, 2018 from https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state/west-virginia-opioid-summary.

National Institute on Drug Abuse (NIDA). (n.d.). Aberrant Drug Taking Behaviors Information Sheet. Retrieved 4/15/2018 from https://www.drugabuse.gov/sites/default/files/files/AberrantDrugTakingBehaviors.pdf.

National Institutes of Health (NIH). (2018). Chronic Pain In Depth. National Center for Complementary and Integrative Health. NCCIH Pub No.: D456. Retrieved 4/13/2018 from https://nccih.nih.gov/health/pain/chronic.htm.

Passik SD. (2009, July). Issues in long-term opioid therapy: Unmet needs, risks, and solutions. Mayo Clin Proc. 84(7):593–601. Retrieved July 5, 2018 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704131/.

Solis M. (2014, October 9). Long-Term Opioid Therapy for Chronic Pain: More Harm Than Good? Appreciation of risks brings new guidelines and an initiative to research non-drug alternatives for pain. Retrieved 4/20/2018 from https://www.painresearchforum.org/news/46387-long-term-opioid-therapy-chronic-pain-more-harm-good.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2018. TIP 63: Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. SMA18-5063FULLDOC. Retrieved 4/14/2018 from https://store.samhsa.gov/shin/content//SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2017a. Behavioral Health Barometer: West Virginia, Volume 4: Indicators as measured through the 2015 National Survey on Drug Use and Health, the National Survey of Substance Abuse Treatment Services, and the Uniform Reporting System. HHS Publication No. SMA–17–Baro–16–States–WV. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2017.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2017b. Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved 4/8/2018 from https://www.samhsa.gov/data/.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2016a). Opioid Overdose Prevention Toolkit: Facts for Community Members, Five Essential Steps for First Responders, Information for Prescribers, Safety Advice for Patients & Family Members, Recovering From Opioid Overdose. HHS Publication No. (SMA) 16-4742. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved 4/13/2018 from https://store.samhsa.gov/shin/content//SMA16-4742/SMA16-4742.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2016b. The CBHSQ Report. September 29, 2016. Rachel N. Lipari, Ph.D, Eunice Park-Lee, Ph.D., and Struther Van Horn, M.A. America’s Need for and Receipt of Substance Use Treatment in 2015. Retrieved 4/20/2018 from https://www.samhsa.gov/data/sites/default/files/report_2716/ShortReport-2716.html.

Substance Abuse and Mental Health Services Administration (SAMHSA), National Survey o Drug Use and Health (NSDUH). (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD. Retrieved 4/20/2018 from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf.

U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA). (2018a).Controlled Substances Schedules. Retrieved 4/20/2018 from https://www.deadiversion.usdoj.gov/schedules/.

U.S. Department of Justice, Drug Enforcement Administration (DEA). (2018b). October 2017 14th National Drug Take Back Day Collection Results. Retrieved 4/7/2018 from https://www.deadiversion.usdoj.gov/drug_disposal/takeback/.

U.S. Attorney’s Office, Southern District of West Virginia. (2014, September). Goodwin Encourages West Virginians to Participate in Upcoming Prescription Drug Take-Back Event. Retrieved April 20, 2018 from http://www.justice.gov/usao/wvs/press_releases/September2014/attachments/0925141_DrugTakeBack.html.

West Virginia Department of Health and Human Resources (WV DHHR). (2018, April 11). DHHR Reseaches Neonatal Abstinence Syndrome Data for 2017. Retrieved 4/20/2018 from https://dhhr.wv.gov/News/2018/Pages/DHHR-Releases-Neonatal-Abstinence-Syndrome-Data-for-2017-.aspx.

Wu SM, Compton P, Bolus R, et al. (2006). The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage. 32(4):342–51. Retrieved 4/20/2018 from http://www.emergingsolutionsinpain.com/images/pdf/reslib/Addiction_Behaviors_Checklist.pdf.

Yudko E, Lozhkina O, Fouts A. (1997, March). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 32(2):189-98. Retrieved 4/20/2018 from http://www.ncbi.nlm.nih.gov/pubmed/17306727.

Zimmerman, Brian. February 28, (2017, February 28). Becker’s Hospital Review. 7 Things to Know About the History of The Joint Commission Pain Standards. Retrieved 4/20/2018 from https://www.beckershospitalreview.com/opioids/7-things-to-know-about-the-history-of-the-joint-commission-pain-standards.html.

You've reached the end of this section